Corcept Therapeutics | Des Atouts



Assets Changement Date
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
ANI Pharmaceuticals USD 1.28B 3.68M 2024-12
Ardelyx USD 435.75M 67.89M 2024-12
Aurora Cannabis CAD 866.52M 57.75M 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
J&J USD 180.1B 1.82B 2024-12
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Merck USD 117.11B 426M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pacira USD 1.55B 31.82M 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
TG Therapeutics USD 577.69M 8.32M 2024-12



Corcept Therapeutics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.